Kratom use in the United States: Response to Grundmann et al
- PMID: 32588454
- DOI: 10.1111/add.15170
Kratom use in the United States: Response to Grundmann et al
Keywords: Drug abuse; NMURx; United States; epidemiology; kratom; mitragyna; mitragynine; opioid; prevalence.
Comment on
-
Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross-sectional study.Addiction. 2021 Jan;116(1):176-181. doi: 10.1111/add.15082. Epub 2020 Apr 28. Addiction. 2021. PMID: 32285981
-
Kratom use in the United States: a diverse and complex profile.Addiction. 2021 Jan;116(1):202-203. doi: 10.1111/add.15173. Epub 2020 Jul 12. Addiction. 2021. PMID: 32602213 Free PMC article. No abstract available.
References
-
- Grundmann O., Babin J. K., Henningfield J. E., Garcia-Romeu A., Kruegel A. C., Prozialeck W. C., et al. Kratom use in the United States: a diverse and complex profile. Addiction 2021; 116: 202-203.
-
- Schimmel J., Amioka E., Rockhill K., Haynes C. M., Black J. C., Dart R. C. et al. Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross-sectional study. Addiction 2021; 116: 176-181.
-
- Garcia-Romeu A., Cox D. J., Smith K. E., Dunn K. E., Griffiths R. R. Kratom (Mitragyna speciosa): user demographics, use patterns, and implications for the opioid epidemic. Drug Alcohol Depend 2020; 208: 107849.
-
- Black J. C., Rockhill K., Forber A., Amioka E., May K. P., Haynes C. M., et al. An online survey for pharmacoepidemiological investigation (Survey of Non-Medical Use of Prescription Drugs Program): validation study. J Med Internet Res 2019; 21: e15830.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
